BIOHIT HealthCare
Search for:
About Us
Back
Strategy and Objectives
History
Back
Company background
Path to success
Milestones in Biohit’s history
Biohit Management
Quality
Research and Development
Career
Glossary
News and Events
Privacy policy
Products
Back
Acetaldehyde Binding Products
Back
Acetium lozenge
Acetium capsule
Diagnostic tests
Back
GastroPanel ELISA
Biohit Active B12 ELISA
Biohit Total 25OH Vitamin D ELISA
Biohit Calprotectin ELISA
Helicobacter Pylori Quick Test
Helicobacter Pylori UFT300 Quick Test
ColonView Quick Test
Lactose Intolerance Quick Test
Celiac Disease Quick Test
Monoclonal Antibodies
Back
Human Gastric Biomarkers
Phytoestrogen Genistein
Human Extracellular Matrix Components (ECM)
Human Integrins, Human Endothelial Cell Surface Marker
Human Cytoskeletal Polypeptides
Human Neurotransmitter Substances
Human Spectrins
Dysbiosis
Back
GA-map Dysbiosis Test
Instruments
Back
Microplate Readers and Washers
Quick Test Readers
ELISA Automates
Product Brochures
Scientific
Back
Key Biohit studies
Study protocols
Presentations
Literature
Laboratory
Back
Determination of Acetaldehyde
How to reduce acetaldehyde exposure
Investors
Back
Stock Exchange Releases
Back
Order Releases
Shareholders
Back
Number Dispersion
Notifications on major holdings
Holding Distribution
Insider Regulations
Insider Register
Major Shareholders
Strategy
Back
Short term risks and uncertainty factors
Biohit’s view on 2018
Financials
Back
Key Ratios
Financial reports
Profit share proposal
Annual Reports
Operating Environment
Share Information
Back
Share Capital
Redemption Rights
Share Monitor
Share History
Corporate Governance
Group Management
Back
President
Board of Directors
Subsidiary management
Management
Shareholder Meetings
Fact sheet for investors
IR calender
Partnering
Back
Acetium partnering
GastroPanel partnering
Contact
Back
Locations
Distributors
Order Releases
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Privacy policy